Archive for October 2011
Alex Dahl to Speak on Panel at The Partnership for Safe Medicines Interchange 2011
Alex Dahl will speak on the panel, “Protecting Our Medicines.” He is a member of The Coalition for Patient Safety and Medicine Integrity which is a group of pharmaceutical, medical device and medical products companies focused on patient safety.
Its purpose is to protect patients from the risks posed by stolen and inappropriately handled medical products re-entering the legitimate supply chain. The Coalition includes: Abbott Laboratories, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Novartis, Novo Nordisk, Sanofi Aventis, and PhRMA.
Partnership for Safe Medicines Opposes Legislation to Undermine Drug Safety Enforcements
Public Health Group Urges Senators to Prevent Influx of Counterfeit Medicines and Ensure Patient Safety by Opposing Vitter Importation Amendment Washington, D.C. (October 19, 2011) – Legislation that would prohibit the US Food and Drug Administration (FDA) from stopping the importation of potentially unsafe medicines, including those sold over the Internet, would raise the risk…
[...]SMS for Life and mPedigree Acknowledged as Most Innovative Technologies Innovation Award from Wall Street Journal
Saving Lives with SMS for Life Photo by ibmphoto24, via Flickr. The Wall Street Journal’s Innovation Award judges recognized two health care IT projects that use cell phone technology to provide access to medication to patients in Africa. Judges chose the SMS for Life Project as the most innovative technology in Health-Care IT…
[...]Sen. Vitter’s Proposed Amendment Raises Drug Safety Concerns
[The Senate is marking up the House's Agricultural Appropriations Bill (HR 2112). They are considering an amendment (#769) proposed by Senator Vitter which would allow for drug importation. The Partnership for Safe Medicines sent this letter to all members of the Senate today to urge them to oppose importation.] Dear Senator, As a public health group…
[...]Researchers Show Fake Medicine Spammers Infiltrating Twitter
A new study by the University of Akron shows Twitter is a new forum for spammers to reach potential clients in counterfeit medicine scams. Say researchers Chandra Shekar, Kathy J. Liszka, and Chien-Chung Chan, “Spammers have pounced on this new opportunity for a fast and dishonest dollar, disseminating pornography, fake lotteries, fake inheritances, counterfeit watches,…
[...]Teva Pharmaceutical Industries Sponsors Partnership for Safe Medicines Interchange 2011
Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world’s largest generic drug maker, with a global product portfolio of more than…
[...]Partnership for Safe Medicines Executive Director Speaks at Brazil Counterfeit Drug Forum
Washington, D.C. (October 17, 2011) – Addressing the growing public health crisis posed by counterfeit medicines in Brazil requires the coordinated effort of all stakeholders across the country, said Partnership for Safe Medicines Executive Director Scott LaGanga during a forum today in Rio de Janeiro on counterfeit medicines hosted by Interfarma and Brazilian newspaper O…
[...]PSM Executive Director Headlines Brazil Counterfeit Medicines Forum
PSM Executive Director Scott LaGanga joined public and private sector leaders from across Brazil today to discuss the critical need to address the growing and borderless counterfeit medicines epidemic, an issue that Brazilian Justice Minister José Eduardo Cardozo called “one of the most important to Brazilian society.”
The event, hosted by Interfarma and O Globo, featured the Brazilian Institute of Public Opinion and Statistics (IBOPE) release of a national opinion survey which found that more education is needed to ensure that consumers are informed of the dangers associated with counterfeit medicines.
According to the survey, nearly 30 percent of Brazilian consumers do not verify if a prescribed or over-the-counter medicine is still within its due date. More than half “ignore the security seal.”
“By no means is this issue getting any easier to address,” said Scott LaGanga. “To be effective in the long-term, we need global collaboration on the part of both government and the private sector. Only then can we put our best foot forward in protecting millions of patients from the life-threatening risks associated with counterfeit drugs.”
Kibble Image
Deputy Director of ICE Keynote Speaker for Interchange
Kumar C. Kibble will be the keynote speaker for The Partnership for Safe Medicine’s Interchange on October 27, 2011 at the National Press Club.
Kumar C. Kibble is the deputy director for U.S. Immigration and Customs Enforcement (ICE). In that capacity, he is the chief operating officer for the principal investigative agency of the Department of Homeland Security, with more than 20,000 employees assigned to more than 400 offices worldwide and an annual budget of almost $6 billion.